Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A

Autor: Delphine S. Courvoisier, Olivier Poirot, Jean-Claude Martinou, Estelle Arnaud, Roman Chrast, Jean-Jacques Médard, Romain Cartoni
Jazyk: angličtina
Rok vydání: 2010
Předmět:
Aging
Glutamine
Neurons/metabolism
Mitochondrion
medicine.disease_cause
Mitochondrial Membrane Transport Proteins
Nerve Fibers
Myelinated

GTP Phosphohydrolases
Mice
0302 clinical medicine
Charcot-Marie-Tooth Disease
Membrane Transport Proteins/genetics
Axon
Neurons
0303 health sciences
Mutation
Axons/ultrastructure
Sciatic Nerve
Mitochondria
Cell biology
Charcot-Marie-Tooth Disease/genetics/pathology/physiopathology
Mitochondria/ultrastructure
Phenotype
medicine.anatomical_structure
mitochondrial fusion
Mitochondrial Proteins/genetics
Sciatic nerve
Genetically modified mouse
DNA
Complementary

Transgene
DNA
Complementary/metabolism

Mice
Transgenic

Biology
Arginine
Mitochondrial Proteins
03 medical and health sciences
ddc:570
medicine
Animals
Humans
Peripheral Nerves
030304 developmental biology
Nerve Fibers
Myelinated/pathology

Sciatic Nerve/pathology
Membrane Transport Proteins
GTP Phosphohydrolases/genetics
medicine.disease
Axons
Peripheral Nerves/ultrastructure
Microscopy
Electron

Peripheral neuropathy
Charcot-Marie-Tooth Disease/genetics
Charcot-Marie-Tooth Disease/pathology
nervous system
Neurology (clinical)
Neuroscience
030217 neurology & neurosurgery
Zdroj: Brain, vol. 133, no. Pt 5, pp. 1460-1469
Brain : a journal of neurology
Brain
Brain, Vol. 133, No Pt 5 (2010) pp. 1460-1469
ISSN: 0006-8950
Popis: Charcot-Marie-Tooth disease type 2A is an autosomal dominant axonal form of peripheral neuropathy caused by mutations in the mitofusin 2 gene. Mitofusin 2 encodes a mitochondrial outer membrane protein that participates in mitochondrial fusion in mammalian cells. How mutations in this protein lead to Charcot-Marie-Tooth disease type 2A pathophysiology remains unclear. We have generated a transgenic mouse expressing either a mutated (R94Q) or wild-type form of human mitofusin 2 in neurons to evaluate whether the R94Q mutation was sufficient for inducing a Charcot-Marie-Tooth disease type 2A phenotype. Only mice expressing mitofusin 2(R94Q) developed locomotor impairments and gait defects thus mimicking the Charcot-Marie-Tooth disease type 2A neuropathy. In these animals, the number of mitochondria per axon was significantly increased in the distal part of the sciatic nerve axons with a diameter smaller than 3.5 microm. Importantly, the analysis of R94Q transgenic animals also revealed an age-related shift in the size of myelinated axons leading to an over-representation of axons smaller than 3.5 microm. Together these data suggest a link between an increased number of mitochondria in axons and a shift in axonal size distribution in mitofusin 2(R94Q) transgenic animals that may contribute to their neurological phenotype.
Databáze: OpenAIRE